This latest twist during the Lykos Therapeutics saga threatens An important overhaul of the corporation’s system and route, with Musk ally and billionaire investor Antonio Gracias showing to want to consider the corporate again toward its nonprofit drug growth roots and a far more Doblinite philosophy.“There’s gonna be a lot of applications t